Sarepta Therapeutics, Inc. · NASDAQ:SRPT

BlackRock, Inc. reported a 15.80% stake in Sarepta Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Jul 30, 2026

BlackRock, Inc. reported a 15.80% stake in Sarepta Therapeutics, Inc., 16,642,620 shares, as a passive investor on Jun 30, 2026. Filed Jul 30, 2026 (Schedule 13G/A).

Stake
15.80%
Shares
16,642,620
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.15.80%16,642,620

Source

View original at SEC

Related